Summit Therapeutics Registers for Secondary Offering of 10.4 Million Shares
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.50 USD | +1.94% |
|
+2.60% | +14.88% |
Jan. 13 | Summit Therapeutics Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 03:00 PM | |
Jan. 08 | Truist Initiates Summit Therapeutics at Buy With $35 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration